LONDON, September 26 /PRNewswire/ -- Scrip's new Pharmaceutical Company League Tables, 2007 report shows that Pfizer dropped to second place behind Johnson &Johnson (J&J) in the list of companies ranked by total revenue across all business divisions.
Only 43% of J&J's revenue comes from sales of pharmaceuticals whereas Pfizer is predominantly a pharma business. Consequently, J&J has perhaps struggled less than Pfizer in pharma's tough operating conditions in 2006 - caused by patent expiries, tightening healthcare budgets and a stricter regulatory climate in the aftermath of the Vioxx withdrawal.
This new report also shows that, despite a major acquisition (of Schering AG in October 2006 for $22 billion), Bayer dropped from fourth to fifth in the same table while Merck KGaA rose from 26th to 24th after its acquisition of Serono for US$14 billion in September 2006.
And, while the world's top ten companies are the same as in 2006, most moved places in the listing.
The report includes 24 further tables that enable one to see at a glance how the world's top pharmaceutical, biotech and generics companies perform financially in relation to one another. Using information from the annual reports of more than 100 companies, this report enables one to compare sales, profit, assets and expenditure figures over the 2006 financial year.
The 105-page print or PDF report is accompanied by Microsoft Excel(R) Pivot Tables (R), which contain up to 11 years of company financial information that can be compared against a number of indicators for customised analysis of the pharmaceutical industry's performance and prospects.
Scrip Reports publishes an extensive range of pharmaceutical
therapeutic market reports, detailed analyses of the pharmaceutical market
for specific geographic areas, in-depth profiles of companies operating in
the industry, financial and statistical analyses, directories and other
strategic reports on the healthcare sector.
|SOURCE Scrip Reports|
Copyright©2007 PR Newswire.
All rights reserved